Development of NMR and thermal shift assays for the evaluation of <i>Mycobacterium tuberculosis</i> isocitrate lyase inhibitors.

Document

Basic Information

ID: CHEMBL4257464
Journal: Medchemcomm
Title: Development of NMR and thermal shift assays for the evaluation of <i>Mycobacterium tuberculosis</i> isocitrate lyase inhibitors.
Authors: Bhusal RP, Patel K, Kwai BXC, Swartjes A, Bashiri G, Reynisson J, Sperry J, Leung IKH.
Abstract: The enzymes isocitrate lyase (ICL) isoforms 1 and 2 are essential for <i>Mycobacterium tuberculosis</i> survival within macrophages during latent tuberculosis (TB). As such, ICLs are attractive therapeutic targets for the treatment of tuberculosis. However, there are few biophysical assays that are available for accurate kinetic and inhibition studies of ICL <i>in vitro</i>. Herein we report the development of a combined NMR spectroscopy and thermal shift assay to study ICL inhibitors for both screening and inhibition constant (IC<sub>50</sub>) measurement. Operating this new assay in tandem with virtual high-throughput screening has led to the discovery of several new ICL1 inhibitors.
CiteXplore: 30108733
Patent ID: ---

Compound Summaries

Associated Compounds for document CHEMBL4257464 (Development of NMR and thermal shift assays for th...) (32)
Histogram Settings


1.67 3.33 5 6.67 8.33 10 [79.79, 119.68) [119.68, 159.57) [159.57, 199.47) [199.47, 239.36) [239.36, 279.26) [279.26, 319.15) [319.15, 359.04) [359.04, 398.94) [398.94, 438.83) [438.83, 478.72) [478.72, 494.55]
Total
32
Global Bio Data logo
ChEMBL is part of the ELIXIR infrastructure
ChEMBL is and Elixir Core Data Resource Learn More
Global Bio Data logo
ChEMBL is a Global Core Biodata Resource